Comparison of two diagnostic intervention packages for community-based active case finding for tuberculosis: an open-label randomized controlled trial

Author:

Esmail Aliasgar,Randall Philippa,Oelofse Suzette,Tomasicchio Michele,Pooran Anil,Meldau Richard,Makambwa Edson,Mottay Lynelle,Jaumdally Shameem,Calligaro GregoryORCID,Meier Stuart,de Kock Marianna,Gumbo Tawanda,Warren Robin Mark,Dheda KeertanORCID

Funder

European and Developing Countries Clinical Trials Partnership

RCUK | Medical Research Council

CRDF Global

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference43 articles.

1. World Health Organization. Global Tuberculosis Report (WHO, 2020).

2. World Health Organization. Systematic Screening for Active Tuberculosis: Principles and recommendations (WHO, 2013).

3. Madhi, S. A. et al. COVID-19 lockdowns in low- and middle-income countries: success against COVID-19 at the price of greater costs. S. Afr. Med. J. 110, 724–726 (2020).

4. Dheda, K. et al. The intersecting pandemics of tuberculosis and COVID-19: population-level and patient-level impact, clinical presentation, and corrective interventions. Lancet Respir. Med. 10, 603–622 (2022).

5. Dheda, K. et al. The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis. Lancet Respir. Med. S2213-2600, 30079-6 (2017).

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3